We are live on ! Find out more
TELA icon

TELA Bio
TELA

32 hedge funds and large institutions have $73.8M invested in TELA Bio in 2022 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 11 increasing their positions, 6 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 2 → 4 (+2)

83% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 6

33% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 6

16.25% more ownership

Funds ownership: 76.71% → 92.96% (+16%)

7% more funds holding

Funds holding: 30 → 32 (+2)

43% less capital invested

Capital invested by funds: $130M → $73.8M (-$56M)

Holders
32
Holders Change
+2
Holders Change %
+6.67%
% of All Funds
0.54%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.07%
New
8
Increased
11
Reduced
6
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
OM
Opaleye Management
Massachusetts
+$9.68M
2
IV
Industry Ventures
California
+$4.81M
3
ACM
AIGH Capital Management
Maryland
+$2.54M
4
HLA
Hamilton Lane Advisors
Pennsylvania
+$2.2M
5
EWM
Essex Woodlands Management
Texas
+$2.07M

Top Sellers

1
SAM
Silvercrest Asset Management
New York
-$4.61M
2
AC
Armistice Capital
New York
-$2.23M
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$190K
4
Two Sigma Investments
Two Sigma Investments
New York
-$123K
5
JAMONY
Jacob Asset Management of New York
California
-$107K
Name Holding Trade Value Shares
Change 		Change in
Stake
EWM
1
Essex Woodlands Management
Texas
$25M +$2.07M +249,473 +8%
OM
2
Opaleye Management
Massachusetts
$11.5M +$9.68M +1,166,367 +245%
RI
3
RTW Investments
New York
$7.13M – – –
IV
4
Industry Ventures
California
$4.06M +$4.81M +579,745 New
PVI
5
Pura Vida Investments
New York
$3.9M -$98K -11,797 -2%
VCIM
6
Velan Capital Investment Management
Georgia
$3.49M +$389K +46,838 +10%
Vanguard Group
7
Vanguard Group
Pennsylvania
$2.75M – – –
PCM
8
Pentwater Capital Management
Florida
$2.73M +$646K +77,762 +25%
ACM
9
AIGH Capital Management
Maryland
$2.16M +$2.54M +306,464 New
HLA
10
Hamilton Lane Advisors
Pennsylvania
$1.85M +$2.2M +264,366 New
GPCM
11
Granite Point Capital Management
Massachusetts
$1.6M – – –
JG
12
Jefferies Group
New York
$1.02M +$1.21M +145,507 New
SSA
13
Schonfeld Strategic Advisors
New York
$984K -$44.5K -5,364 -4%
WVP
14
Worth Venture Partners
New Jersey
$904K +$938K +113,012 New
JAMONY
15
Jacob Asset Management of New York
California
$825K -$107K -12,899 -10%
PHP
16
Parkman Healthcare Partners
Connecticut
$764K +$3.98K +480 +0.4%
SMH
17
Sanders Morris Harris
Texas
$674K -$74.7K -9,000 -9%
BCM
18
Bridgeway Capital Management
Texas
$547K +$125K +15,000 +24%
Geode Capital Management
19
Geode Capital Management
Massachusetts
$486K +$28.6K +3,447 +5%
PNC Financial Services Group
20
PNC Financial Services Group
Pennsylvania
$376K +$53.4K +6,433 +14%
Millennium Management
21
Millennium Management
New York
$272K +$318K +38,263 New
WP
22
WMS Partners
Maryland
$197K – – –
State Street
23
State Street
Massachusetts
$185K – – –
BlackRock
24
BlackRock
New York
$103K -$56.4K -6,798 -32%
Northern Trust
25
Northern Trust
Illinois
$98K -$7.62K -918 -6%
1
2

TELA Hedge Fund Activity: Q2 2022 in Review

32 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in TELA Bio (TELA) for Q2 2022, worth a combined $73.8M — down 43% from $130M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new TELA positions and 6 closed out — a net gain of 2 holders — while 11 added to existing stakes and 6 trimmed.

The largest buyer was Opaleye Management, adding an estimated $9.68M. The largest seller was Silvercrest Asset Management, exiting entirely with an estimated $4.61M sold.

  • 32 institutional investors held TELA Bio (TELA) as of Q2 2022, up from 30 in Q1 2022.
  • Funds reported $73.8M of TELA Bio stock for Q2 2022, down 43% quarter-over-quarter.
  • 8 funds opened new TELA Bio positions in Q2 2022 and 6 closed out, a net change of +2 holders.
  • The largest TELA Bio buyer in Q2 2022 was Opaleye Management, an estimated $9.68M added.
  • The largest TELA Bio seller in Q2 2022 was Silvercrest Asset Management, an estimated $4.61M sold.

Based on aggregated 13F filings for Q2 2022.